[Glucose transport inhibition in human erythrocytes by calmodulin antagonists]

Tsitologiia
|September 1, 1986
PubMed

Insights

Calmodulin antagonists block glucose transport in human red blood cells by affecting the carrier-sugar complex. Calcium ionophores reverse this inhibition, suggesting a calmodulin-dependent mechanism.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Pharmacology

Context:

  • Glucose transport is crucial for erythrocyte energy metabolism.
  • Calmodulin is a key calcium-binding protein involved in cellular signaling.
  • Erythrocytes lack mitochondria and rely solely on glycolysis for ATP production.

Purpose:

  • To investigate the effect of calmodulin antagonists on glucose transport in human erythrocytes.
  • To elucidate the mechanism underlying the inhibition of glucose transport by these antagonists.
  • To explore the role of calcium ions and calmodulin in regulating glucose transport.

Summary:

  • Calmodulin antagonists (tryphtazin, lidocaine, dykain, palmitate) were found to inhibit glucose transport in human erythrocytes.
  • The inhibition was concentration-dependent and uncompetitive, decreasing the maximum transport rate but not the dissociation constant of the carrier-sugar complex.
  • Calcium ionophores (A23187, divaleryldibenzo-18-crown-6) abolished the inhibitory effects, indicating a calmodulin-dependent pathway.

Impact:

  • Suggests a novel regulatory mechanism for glucose transport in erythrocytes involving calmodulin.
  • Provides insights into the potential therapeutic targets for modulating glucose metabolism.
  • Highlights the interplay between calcium signaling and carbohydrate transport.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a DNA...
Glucose Transporters01:27

Glucose Transporters

Glucose transporters facilitate the transport of glucose across the cell membrane. In addition to glucose, some glucose transporters can also aid the movement of other hexoses such as fructose, mannose, and galactose.
Facilitated diffusion-glucose transporters (GLUTs) are encoded by the solute-linked carrier (SLC) family 2, subfamily A gene family, or SLC2A. The 14 GLUT protein members are distributed into three classes:
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
Glucose Homeostasis: Regulation of Blood Glucose01:02

Glucose Homeostasis: Regulation of Blood Glucose

Carbohydrates consumed through foods are converted into glucose, a crucial energy source for the body. In the prandial state, high blood glucose levels stimulate the secretion of insulin from the pancreas. Insulin inhibits hepatic glucose production and stimulates glucose uptake and metabolism by muscle and adipose tissue. The excess glucose is converted into glycogen and stored in the liver and muscles.
During fasting, when blood glucose levels are low, the pancreas secretes glucagon. it...
Oral Hypoglycemic Agents: α-Glucosidase Inhibitors01:19

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are typically...
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a significant...